Metabolic and vascular outcomes after transition to the MiniMed 780G system in adults ≥65 years with type 1 diabetes: a randomised, single-centre study
Bartłomiej Matejko, Katarzyna Cyranka, Paulina Suduł, Kamila Susuł, Jakub Krężel, Juliia Chernovol, Paweł Maga, Maciej T. Malecki, Tomasz Klupa · 2026
Read Metabolic and vascular outcomes after transition to the MiniMed 780G system in adults ≥65 years with type 1 diabetes: a randomised, single-centre study by Bartłomiej Matejko, Katarzyna Cyranka, Paulina Suduł, Kamila Susuł, Jakub Krężel, Juliia Chernovol, Paweł Maga, Maciej T. Malecki, Tomasz Klupa (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13424476.txt.
Description
Bartłomiej Matejko and eight colleagues randomise older adults with type 1 diabetes to an advanced hybrid closed-loop insulin system, the MiniMed 780G, or their usual injections or pump, in a single-centre trial. Evidence for automated insulin delivery past age sixty-five is scarce, so thirty-four volunteers aged at least sixty-five, new to the technology, were followed for twelve months.
Twenty-nine finished the study. The closed-loop group improved fast and kept the gain: time spent in the target glucose range climbed from 57.4% at the start to 79.7% at a year, with time spent too high shrinking alongside. Blood vessel status and other glucose measures served as secondary outcomes. The authors support offering the system to older patients.
Catalog record
| CREATOR | Bartłomiej Matejko, Katarzyna Cyranka, Paulina Suduł, Kamila Susuł, Jakub Krężel, Juliia Chernovol, Paweł Maga, Maciej T. Malecki, Tomasz Klupa |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41781 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |